AI and Mini Brains Are Changing How Future Medicines Are Made
From lab-grown brain tissues to autonomous AI systems for molecule design, the pharmaceutical industry is undergoing a profound transformation. McKinsey estimates that generative AI could shorten the drug discovery process by as much as 50 percent.